Top Markets
#1 Islamic Coin Islamic Coin +151.65%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.95%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#4 clBTC clBTC +12.10%
#5 OpenEden OpenEden +11.81%
#6 Akedo Akedo +11.20%
#7 Arowana Arowana +9.99%
#8 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.90%
#9 Mantle Staked Ether Mantle Staked Ether +8.50%
#10 MarsCoin MarsCoin +8.30%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.

INFI
Rang in Aktien #40134
Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge,... Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.
Aktienkurs
$0.0039
Zuletzt synchronisiert: 2023-10-27
Marktkapitalisierung
$235.97K
Veränderung (1 Tag)
-13.33%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Infinity Pharmaceuticals, Inc. (INFI)

Kategorie

Healthcare
Preis INFI mit Marktkapitalisierung von B
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
INFI
$0.0039
Marktkapitalisierung von Infinity Pharmaceuticals, Inc.(INFI)
Marktkapitalisierung: $235.97K
Mit Stand August 2026 hat Infinity Pharmaceuticals, Inc. eine Marktkapitalisierung von $235.97K. Das macht Infinity Pharmaceuticals, Inc. laut unseren Daten zum 40134th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Infinity Pharmaceuticals, Inc. von 2000 bis 2026
INFI im Vergleich zu den Top 5 der beliebtesten stocks
Preis für INFI Vermögenswert B Marktkapitalisierung von B Ergebnisse
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$90,396.06 $235.97K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +2,317,847,615.15%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$73,828.11 $235.97K
Apple Inc. Apple Inc.
AAPL
$4.467T +1,893,028,379.22%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$68,990.85 $235.97K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +1,768,996,165.18%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$61,151.86 $235.97K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +1,567,996,335.13%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$47,174.25 $235.97K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +1,209,596,025.46%